Hemingway Maureen W, Meleis Laura, Oliver Jevon, Silvestri Sandra
AORN J. 2020 Mar;111(3):289-300. doi: 10.1002/aorn.12960.
Hazardous drug (HD) use in the perioperative environment poses unique challenges and risks for exposure that can have adverse consequences for perioperative personnel. The United States Pharmacopeial Convention has implemented new standards to address the safe handling and administration of HDs by health care workers. To comply with these standards and minimize perioperative personnel's occupational exposure to HDs, a multidisciplinary team at an academic medical center in Boston that was performing an increased number and variety of operative and other invasive procedures using antineoplastic agents updated their protocol for the safe use of HDs in the OR. This article discusses HDs and the risks they pose to health care workers and outlines the new HD safety protocol for the OR that was part of a performance improvement plan to ensure compliance with new standards and staff member safety in the perioperative setting.
在围手术期环境中使用危险药物（HD）会带来独特的挑战和暴露风险，这可能会对围手术期工作人员产生不良后果。美国药典委员会已实施新标准，以规范医护人员对HD的安全处理和使用。为了遵守这些标准并尽量减少围手术期工作人员职业接触HD的情况，波士顿一家学术医疗中心的一个多学科团队更新了其手术室HD安全使用方案，该中心正在进行越来越多且种类繁多的使用抗肿瘤药物的手术及其他侵入性操作。本文讨论了HD及其对医护人员构成的风险，并概述了手术室新的HD安全方案，该方案是一项绩效改进计划的一部分，旨在确保在围手术期环境中符合新标准并保障工作人员安全。
